Table II.
Reportable telehealth metrics
| Metric | Outcome |
|---|---|
| No. of visits | In-person, tele-allergy |
| Patient characteristics | Age, sex, ethnicity, socioeconomic status, insurance type, etc |
| Type of appointment | New vs follow-up |
| Modality of patient communication | In-person, telephone, synchronous without facilitator, mHealth, telementoring, etc |
| Originating site (patient location) | Home, clinic, school, medical center, etc |
| Population density at patient location | Urban, suburban, rural |
| Distance from allergist | miles, km |
| Time “saved” by using telehealth | Work and/or school days “saved” |
| “Green” effect | Environmental implications if driving not required (eg, CO2 emissions, etc) |
| % follow-up recommended | Percentage |
| % follow-up completed | Percentage |
| Standardized outcomes | ACT, UCT, UAS7, SNOT, ED visits, hospitalizations, QOL surveys, etc |
| Allergy visits conducted via telehealth | Percentage |
| Telehealth visits per service compared with overall hospital visits | Percentage |
| Patient satisfaction | Percentage satisfied/dissatisfied |
| Provider satisfaction | Percentage satisfied/dissatisfied |
| No. of patient engagements | Number (eg, telephone call, home visits, and school visits) |
| No. of originating sites | Number |
| No. of encounters per originating site | Number |
| wRVUs generated | Originating site; distant site |
| Specialty no-show rate | In-person vs telehealth |
| No. of days to first open appointment | In-person vs telehealth |
| Appointment availability | Weekday vs weekend; business hours vs “after hours” |
ACT, Asthma Control Test; ED, emergency department; QOL, quality of life; RVU, relative value unit; UAS7, Urticaria Activity Score 7; SNOT, Sino-Nasal Outcome Test; UCT, Urticaria Control Test.